Ebixa 10 mg Tablets contain memantine hydrochloride, a prescription medicine used to treat moderate to severe Alzheimer's disease in adults.

Memantine is an NMDA receptor antagonist that works by regulating the activity of glutamate, a neurotransmitter involved in learning and memory. It may help improve or maintain cognitive function and everyday functioning in some patients with Alzheimer's disease.

Active Ingredient:
Each film-coated tablet contains memantine hydrochloride 10 mg.

Key Information:

• Indicated for moderate to severe Alzheimer's disease.

• Helps manage symptoms associated with Alzheimer's disease.

• Acts on NMDA receptors involved in nerve signal transmission.

• Pack contains 28 film-coated tablets.

How to Use:
Take orally once daily, at the same time each day, with or without food, as prescribed by a physician. Treatment usually starts at 5 mg once daily and is gradually increased to a recommended maintenance dose of 20 mg daily, depending on tolerability and kidney function. Do not adjust the dose without medical advice.

Possible Side Effects:
Common side effects may include headache, dizziness, constipation, drowsiness, and increased blood pressure. Consult a healthcare professional if side effects persist or become troublesome.

Disclaimer:
Prescription medicine. Use only under medical supervision. Ebixa does not cure Alzheimer's disease. Dose adjustments may be required in patients with kidney impairment. Consult your physician before use, especially if you have kidney problems, a history of seizures, or take other medications.

This description is suitable for pharmacy e-commerce and is aligned with the official Ebixa prescribing information.